Director of Research & Development
Cresilon
This listing was originally posted on Cresilon's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moCresilon® is a Brooklyn-based biotechnology and medical device company that develops, manufactures, and markets hemostatic products, driven by a singular mission: to save lives. Powered by proprietary plant-based hydrogel technology, Cresilon's products are redefining the standard of care by stopping bleeding in seconds across diverse patients, procedures and care settings. The company's current commercial portfolio includes TRAUMAGEL® for human trauma and VETIGEL® for veterinary applications, with planned expansion into human surgical applications and beyond. Learn more at www.cresilon.com
The Director of Research & Development will lead a multidisciplinary team of scientists and engineers, focusing on the development of innovative hemostasis medical devices for both animal health and human markets. This role encompasses the full spectrum of fundamental technology, materials, process, product, and device application development, from early-stage concept research and feasibility assessments to product scale-up, launch, and comprehensive product life-cycle management. They will support the identification of new technologies, materials, processes, and product opportunities and drive acceleration opportunities to support a robust portfolio, and ensure the successful launch of all product programs.
The Director of Research & Development will be responsible for building internal capabilities, recruiting and onboarding top talent, and leading cross-functional, interdisciplinary teams. The Director will also execute a strategic, multi-year technical vision to drive a robust pipeline of customer-centric innovations. Success in this role will require demonstrated expertise in high-impact technology program development and flawless execution, supported by strategic business and technology planning. Additionally, the Director will leverage New Product Introduction (NPI) stage-gate processes to ensure efficient and effective product launches. This role reports directly to the Vice President of Technology.
This is a full-time, on-site position, located in Brooklyn, New York.
Responsibilities:
Preferred Qualifications
Cresilon is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.
This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, training, and apprenticeship. Cresilon makes hiring decisions based solely on qualifications, merit, and business needs at the time. Cresilon is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.
This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, training, and apprenticeship. Cresilon makes hiring decisions based solely on qualifications, merit, and business needs at the time.
If you are an individual with a disability and require a reasonable accommodation to complete any part of the application process and need an alternative method for applying, please contact our Human Resources Department at 347-497-7984 or email Kduffy@cresilon.com.
Preferred Qualifications
Cresilon is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.
This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, training, and apprenticeship. Cresilon makes hiring decisions based solely on qualifications, merit, and business needs at the time. Cresilon is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, sex, religion, sexual orientation, national origin, disability, genetic information, pregnancy, or any other protected characteristic as outlined by federal, state, or local laws.
This policy applies to all employment practices within our organization, including hiring, recruiting, promotion, termination, layoff, recall, leave of absence, compensation, benefits, training, and apprenticeship. Cresilon makes hiring decisions based solely on qualifications, merit, and business needs at the time.
If you are an individual with a disability and require a reasonable accommodation to complete any part of the application process and need an alternative method for applying, please contact our Human Resources Department at 347-497-7984 or email Kduffy@cresilon.com.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Cresilon?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Hemostatic Gel
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo